6
Oct
2026
LMP
Exhibitor at CPHI Milan 2026 stand 16F44, Finished Dosage & Formulation
About Us
Categories
-
Country/Region:Latvia
-
On CPHI since:2018
-
Certificates:1
-
Employees:1 - 24
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 16F44, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Permethrin LMP 50 mg/g gel
Therapeutic indications
Permethrin LMP 50 mg/g gel is indicated for the treatment of scabies infestation in adults, adolescents and children above 2 months of age.
Method of administration
Gel should be applied as ...
LMP Resources (1)
-
Brochure About LMP LLC
Limited Liability Company “LMP” is established on 8th April 1992 – we are a pharmaceutical manufacturing company, which develops, manufactures and sells finished dosage forms for topical use – solutions, gels, creams and ointments. These are quality products effective for treatment of different kind of skin lesions, mucous membrane and upper respiratory tract diseases, as well as muscles pain and pain caused by trauma.
There are more than 20 products currently manufactured by LMP.
Products basically are sold in Latvia and exported to other countries: Lithuania, Estonia, The Netherlands, Poland, Portugal, Czech Republic, Slovakia, Hungary, United Arab Emirates, Armenia, Azerbaijan, Georgia, Kazakhstan, Kosovo, Ukraine.
